Press + media

Explore the New Frontier of Pharma

With the latest Windgap news, research, and events

Get the Latest

Featured
Injecting Sustainability: The 4th “R”—Responsibility
Injecting Sustainability
Injecting Sustainability: The 4th “R”—Responsibility
Injecting Sustainability

How Windgap is reducing environmental impact through innovation, partnerships, and a proactive approach.

Injecting Sustainability
Reducing Energy: Eliminating The Cold Chain
Injecting Sustainability
Reducing Energy: Eliminating The Cold Chain
Injecting Sustainability

How Windgap Medical’s lyophilized autoinjector platforms cut CO2 Emissions and Costs

Injecting Sustainability
Reducing Operational Waste: Streamlining Drug Development with Innovative Autoinjectors
Injecting Sustainability
Reducing Operational Waste: Streamlining Drug Development with Innovative Autoinjectors
Injecting Sustainability

Discover how automating, accelerating, and simplifying complex drug delivery can save time, resources, energy—and the planet.

Injecting Sustainability
Injecting Sustainability: Maximizing Complex Formulations to Minimize Carbon Footprints
Injecting Sustainability
Injecting Sustainability: Maximizing Complex Formulations to Minimize Carbon Footprints
Injecting Sustainability

Find out how lyophilization, long-acting injectables, and sequential delivery can substantially reduce waste and environmental impact.

Injecting Sustainability
Challenging the “3R” Rhetoric in the Autoinjector Industry
Injecting Sustainability
Challenging the “3R” Rhetoric in the Autoinjector Industry
Injecting Sustainability

Pharmaceutical companies that want to ‘move the needle’ on sustainability efforts can take a more proactive approach to reduce their footprints. Here’s why.

Injecting Sustainability
Windgap Medical Profiled on ‘Drug Development & Delivery’ Website
Articles
Windgap Medical Profiled on ‘Drug Development & Delivery’ Website
Articles

Windgap Medical offers drug delivery devices that simplify, auto-mate, and accelerate the administration of complex injectables.

Articles
In The Thick Of It: Accelerating The Mixing And Delivery Of High-viscosity Injectables
Articles
In The Thick Of It: Accelerating The Mixing And Delivery Of High-viscosity Injectables
Articles

Brent Buchine, Miriam Silton, Jameson Woods and Andrew Ryan explore how the combination of gas power and a side-by-side cartridge configuration increases the working viscosity range for the mixing and delivery of complex injectable formulations.

Articles
Windgap Medical Appoints Max Meehan as Director of Corporate Development and Strategy
Press + Media
Windgap Medical Appoints Max Meehan as Director of Corporate Development and Strategy
Press + Media

Windgap Medical Appoints Max Meehan as Director of Corporate Development and Strategy

Press + Media
Windgap Medical Appoints Jason Durkin as Vice President, SupplyChain
Press + Media
Windgap Medical Appoints Jason Durkin as Vice President, SupplyChain
Press + Media

The autoinjector platform company known for its wet-dry drug delivery technology expands the leadership team.

Press + Media
Windgap Medical Appoints Anthony (“Tony”) Watson as Vice President, Regulatory Affairs and Quality
Press + Media
Windgap Medical Appoints Anthony (“Tony”) Watson as Vice President, Regulatory Affairs and Quality
Press + Media

The autoinjector platform company known for its wet-dry drug delivery technology expands the leadership team.

Press + Media
Windgap Medical Appoints Aaron Mann as CEO, Michael Samar as CFO
Press + Media
Windgap Medical Appoints Aaron Mann as CEO, Michael Samar as CFO
Press + Media

The autoinjector platform company known for its wet-dry drug delivery technology deepens its leadership bench.

Press + Media
Patient-centric Design Can Be a Faster Path to Market
Articles
Patient-centric Design Can Be a Faster Path to Market
Articles

Brent Buchine considers a faster path to market for automated and easy-to-use reconstitution devices through simplification of the delivery systems.

Articles
It’s Time to Level Up Lyo – Introducing a Swift Shift in Dual-chamber Autoinjector Technology
Articles, Press + Media, Research
It’s Time to Level Up Lyo – Introducing a Swift Shift in Dual-chamber Autoinjector Technology
Articles, Press + Media, Research

Co-Founder Brent Buchine discusses the need for automated, easy-to-use reconstitution devices, especially in lyophilised medications, and introduces Windgap Medical’s technology platforms, which rise to the challenge.

Articles, Press + Media, Research
Windgap Medical, Inc. Closes Over $39 Million of Series B-1 Investment, More Than Twenty Percent Over Its Initial Goal
Press + Media
Windgap Medical, Inc. Closes Over $39 Million of Series B-1 Investment, More Than Twenty Percent Over Its Initial Goal
Press + Media

Windgap Medical, Inc., a leading specialty pharmaceutical and drug delivery platform company, announced today that it has successfully completed its final close with over $39 million of Series B-1 equity financing, led by Taiwania Capital.

Press + Media
Windgap Medical and University of Minnesota Twin Cities Receive $3.2 Million NIH Grant to Develop Cyanide Antidote Autoinjector
Press + Media
Windgap Medical and University of Minnesota Twin Cities Receive $3.2 Million NIH Grant to Develop Cyanide Antidote Autoinjector
Press + Media

Under the grant, researchers from the University's Center for Drug Design, College of Pharmacy, and Massachusetts-based pharmaceutical company Windgap Medical are collaborating to design an autoinjector.

Press + Media
Windgap Medical Announces Partnership with ALK-Abelló for its Epinephrine Autoinjector
Press + Media
Windgap Medical Announces Partnership with ALK-Abelló for its Epinephrine Autoinjector
Press + Media

Windgap Medical, Inc. announced today that it has a strategic partnership with ALK-Abelló, A/S ("ALK") to commercialize the company's epinephrine autoinjector (EAI) for the treatment of anaphylactic shock.

Press + Media
Windgap Medical Announces Strategic Investment from Molex Ventures
Press + Media
Windgap Medical Announces Strategic Investment from Molex Ventures
Press + Media

Windgap Medical, Inc. announced today that it has finalized a deal to enable a strategic investment from Molex Ventures, LLC, a subsidiary of Koch Industries ("Molex Ventures").

Press + Media
Massachusetts Life Sciences Center Board Approves New Round of Accelerator Program Loans
Press + Media
Massachusetts Life Sciences Center Board Approves New Round of Accelerator Program Loans
Press + Media

Announces next round of Life Sciences Accelerator Loan Program

Press + Media

Explore the Research

Featured
Windgap Medical Profiled on ‘Drug Development & Delivery’ Website
Windgap Medical Profiled on ‘Drug Development & Delivery’ Website

Windgap Medical offers drug delivery devices that simplify, auto-mate, and accelerate the administration of complex injectables.

In The Thick Of It: Accelerating The Mixing And Delivery Of High-viscosity Injectables
In The Thick Of It: Accelerating The Mixing And Delivery Of High-viscosity Injectables

Brent Buchine, Miriam Silton, Jameson Woods and Andrew Ryan explore how the combination of gas power and a side-by-side cartridge configuration increases the working viscosity range for the mixing and delivery of complex injectable formulations.

Patient-centric Design Can Be a Faster Path to Market
Patient-centric Design Can Be a Faster Path to Market

Brent Buchine considers a faster path to market for automated and easy-to-use reconstitution devices through simplification of the delivery systems.

It’s Time to Level Up Lyo – Introducing a Swift Shift in Dual-chamber Autoinjector Technology
It’s Time to Level Up Lyo – Introducing a Swift Shift in Dual-chamber Autoinjector Technology

Co-Founder Brent Buchine discusses the need for automated, easy-to-use reconstitution devices, especially in lyophilised medications, and introduces Windgap Medical’s technology platforms, which rise to the challenge.

Follow us on LinkedIn

@WindgapMedical